MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Saxagliptin hydrochloride

CAS No. : 709031-78-7

MCE 站：Saxagliptin hydrochloride

产品活性：Saxagliptin hydrochloride (BMS-477118 hydrochloride) 是一种有效，选择性，可逆，竞争性和具有口服活性的二肽基肽酶 4 (DPP-4) (K_i = 0.6-1.3 nM) 抑制剂。Saxagliptin hydrochloride 可用于 2 型糖尿病的研究。

研究领域：Metabolic Enzyme/Protease

作用靶点：Dipeptidyl Peptidase

In Vitro: Saxagliptin (100 nM; 48 hours; INS-1 832/13 cells) treatment significantly induceS β-cell proliferation.
Saxagliptin (100 nM; 48 hours; INS-1 832/13 cells) treatment increases the p-AKT ａnd active β-catenin protein levels, paralleled with the increase of c-myc ａnd cyclin D1 protein expression.
Saxagliptin acts by preventing the degradation of glucagon-like peptide-1 ａnd hence increases secretion of insulin ａnd decreases secretion of glucagon.

In Vivo: Saxagliptin (1 mg/kg; for 12 weeks) treatment in high-fat diet/streptozotocin-induced diabetic rats, significant improvement in pancreas insulin secretion capacity evaluated by hyperglycemia clamp ａnd increased β-cell to α-cell areas ratio are observed.
Saxagliptin dose-dependently inhibits plasma DPP-4 activity in Han-Wistar rats, by ~70% at 7 hours postdose with 1 mg/kg ａnd by ~90% at 7 hours postdose with 10 mg/kg. At 24 hours postdose, ~20% ａnd 70% inhibition, respectively, remained.

相关产品：Talabostat mesylate  |  Puromycin aminonucleoside  |  Vildagliptin  |  1G244  |  Diprotin A TFA  |  Nateglinide  |  DPP-IV-IN-2  |  Prodipine hydrochloride  |  Prolyl Endopeptidase Inhibitor 1  |  Saikogenin A  |  UAMC00039 dihydrochloride  |  Azaleatin  |  Evogliptin tartrate  |  NDMC101  |  NVP-DPP728 dihydrochloride  |  DPP-IV-IN-1

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。